183 related articles for article (PubMed ID: 35707723)
1. The genes controlling normal function of citrate and spermine secretion are lost in aggressive prostate cancer and prostate model systems.
Rye MB; Krossa S; Hall M; van Mourik C; Bathen TF; Drabløs F; Tessem MB; Bertilsson H
iScience; 2022 Jun; 25(6):104451. PubMed ID: 35707723
[TBL] [Abstract][Full Text] [Related]
2. A novel non-canonical Wnt signature for prostate cancer aggressiveness.
Sandsmark E; Hansen AF; Selnæs KM; Bertilsson H; Bofin AM; Wright AJ; Viset T; Richardsen E; Drabløs F; Bathen TF; Tessem MB; Rye MB
Oncotarget; 2017 Feb; 8(6):9572-9586. PubMed ID: 28030815
[TBL] [Abstract][Full Text] [Related]
3. Spermine and citrate as metabolic biomarkers for assessing prostate cancer aggressiveness.
Giskeødegård GF; Bertilsson H; Selnæs KM; Wright AJ; Bathen TF; Viset T; Halgunset J; Angelsen A; Gribbestad IS; Tessem MB
PLoS One; 2013; 8(4):e62375. PubMed ID: 23626811
[TBL] [Abstract][Full Text] [Related]
4. The metabolites citrate, myo-inositol, and spermine are potential age-independent markers of prostate cancer in human expressed prostatic secretions.
Serkova NJ; Gamito EJ; Jones RH; O'Donnell C; Brown JL; Green S; Sullivan H; Hedlund T; Crawford ED
Prostate; 2008 May; 68(6):620-8. PubMed ID: 18213632
[TBL] [Abstract][Full Text] [Related]
5. The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots.
Costello LC; Franklin RB
Mol Cancer; 2006 May; 5():17. PubMed ID: 16700911
[TBL] [Abstract][Full Text] [Related]
6. Zinc and zinc transporters in normal prostate and the pathogenesis of prostate cancer.
Franklin RB; Milon B; Feng P; Costello LC
Front Biosci; 2005 Sep; 10():2230-9. PubMed ID: 15970489
[TBL] [Abstract][Full Text] [Related]
7. Proton MRS of human prostatic fluid: correlations between citrate, spermine, and myo-inositol levels and changes with disease.
Lynch MJ; Nicholson JK
Prostate; 1997 Mar; 30(4):248-55. PubMed ID: 9111602
[TBL] [Abstract][Full Text] [Related]
8. Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer.
Costello LC; Franklin RB
Prostate; 1998 Jun; 35(4):285-96. PubMed ID: 9609552
[TBL] [Abstract][Full Text] [Related]
9. Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer.
Mazzu YZ; Armenia J; Nandakumar S; Chakraborty G; Yoshikawa Y; Jehane LE; Lee GM; Atiq M; Khan N; Schultz N; Kantoff PW
Mol Oncol; 2020 Aug; 14(8):1881-1897. PubMed ID: 32385899
[TBL] [Abstract][Full Text] [Related]
10. Presence of TMPRSS2-ERG is associated with alterations of the metabolic profile in human prostate cancer.
Hansen AF; Sandsmark E; Rye MB; Wright AJ; Bertilsson H; Richardsen E; Viset T; Bofin AM; Angelsen A; Selnæs KM; Bathen TF; Tessem MB
Oncotarget; 2016 Jul; 7(27):42071-42085. PubMed ID: 27276682
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous Detection of Zinc and Its Pathway Metabolites Using MALDI MS Imaging of Prostate Tissue.
Andersen MK; Krossa S; Høiem TS; Buchholz R; Claes BSR; Balluff B; Ellis SR; Richardsen E; Bertilsson H; Heeren RMA; Bathen TF; Karst U; Giskeødegård GF; Tessem MB
Anal Chem; 2020 Feb; 92(4):3171-3179. PubMed ID: 31944670
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial function, zinc, and intermediary metabolism relationships in normal prostate and prostate cancer.
Costello LC; Franklin RB; Feng P
Mitochondrion; 2005 Jun; 5(3):143-53. PubMed ID: 16050980
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial aconitase and citrate metabolism in malignant and nonmalignant human prostate tissues.
Singh KK; Desouki MM; Franklin RB; Costello LC
Mol Cancer; 2006 Apr; 5():14. PubMed ID: 16595004
[TBL] [Abstract][Full Text] [Related]
14. Human prostate cancer ZIP1/zinc/citrate genetic/metabolic relationship in the TRAMP prostate cancer animal model.
Costello LC; Franklin RB; Zou J; Feng P; Bok R; Swanson MG; Kurhanewicz J
Cancer Biol Ther; 2011 Dec; 12(12):1078-84. PubMed ID: 22156800
[TBL] [Abstract][Full Text] [Related]
15. Concepts of citrate production and secretion by prostate. 1. Metabolic relationships.
Costello LC; Franklin RB
Prostate; 1991; 18(1):25-46. PubMed ID: 1987578
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive review of the role of zinc in normal prostate function and metabolism; and its implications in prostate cancer.
Costello LC; Franklin RB
Arch Biochem Biophys; 2016 Dec; 611():100-112. PubMed ID: 27132038
[TBL] [Abstract][Full Text] [Related]
17. A basal stem cell signature identifies aggressive prostate cancer phenotypes.
Smith BA; Sokolov A; Uzunangelov V; Baertsch R; Newton Y; Graim K; Mathis C; Cheng D; Stuart JM; Witte ON
Proc Natl Acad Sci U S A; 2015 Nov; 112(47):E6544-52. PubMed ID: 26460041
[TBL] [Abstract][Full Text] [Related]
18. Spatial differentiation of metabolism in prostate cancer tissue by MALDI-TOF MSI.
Andersen MK; Høiem TS; Claes BSR; Balluff B; Martin-Lorenzo M; Richardsen E; Krossa S; Bertilsson H; Heeren RMA; Rye MB; Giskeødegård GF; Bathen TF; Tessem MB
Cancer Metab; 2021 Jan; 9(1):9. PubMed ID: 33514438
[TBL] [Abstract][Full Text] [Related]
19. Concepts of citrate production and secretion by prostate: 2. Hormonal relationships in normal and neoplastic prostate.
Costello LC; Franklin RB
Prostate; 1991; 19(3):181-205. PubMed ID: 1946039
[TBL] [Abstract][Full Text] [Related]
20. SFRP4 gene expression is increased in aggressive prostate cancer.
Sandsmark E; Andersen MK; Bofin AM; Bertilsson H; Drabløs F; Bathen TF; Rye MB; Tessem MB
Sci Rep; 2017 Oct; 7(1):14276. PubMed ID: 29079735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
